Business
Genentech More than Doubles Investment in Holly Springs, North Carolina Manufacturing Facility
SOUTH SAN FRANCISCO, Calif., January 20, 2026--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North Carolina manufacturing facility. The increased investment will more than double the total commitment for the company’s first-ever East Coast manufacturing facility to approximately $2 billion. The expansion builds on the company’s May 2025 investment announcement, as well as the project’s August 20
About this update from Roche Holding Ltd
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/14523febafa4890387c1ab26a42e12ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GYio7mkYiI9QVIZuNB4dtQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/14523febafa4890387c1ab26a42e12ad","width":480,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion investment in U.S. manufacturing and R&D","length":238,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The expansion will increase production volume and scale manufacturing capacity within the facility, where construction began in August 2025","length":139,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The Holly Springs investment is expected to support more than 2,000 jobs, including 500+ high-wage manufacturing and 1,500+ construction jobs","length":141,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":518,"olType":false},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., January 20, 2026--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North Carolina manufacturing facility. The increased investment will more than double the total commitment for the company’s first-ever East Coast manufacturing facility to approximately $2 billion. The expansion builds on the company’s May 2025 investment announcement, as well as the project’s August 2025 groundbreaking, and reflects Genentech’s continued confidence in the region’s community, workforce, and long-term growth potential.","length":651,"tagName":"p"},{"type":"text","content":"The expanded investment allows Genentech to build out additional production capacity and significantly increase the facility’s output. Set to be operational by 2029, the state-of-the-art facility will produce next-generation treatments for metabolic conditions, such as obesity. By leveraging advanced biomanufact...